ScholarIQanswers from OpenAlex & ORCID
Melody Cobleigh
ResearcherPublications, citations & collaboration network
Melody Cobleigh is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Melody Cobleigh have?
ScholarIQindexed works
Melody Cobleigh has 212 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Melody Cobleigh have?
ScholarIQcitation count
Melody Cobleigh has 21,551 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Melody Cobleigh?
ScholarIQh-index
Melody Cobleigh has an h-index of 47 in OpenAlex.
What is the i10-index of Melody Cobleigh?
ScholarIQi10-index
Melody Cobleigh has an i10-index of 88 in OpenAlex.
What is the ORCID of Melody Cobleigh?
ScholarIQorcid
The ORCID for Melody Cobleigh is on the source record.
What is the OpenAlex record for Melody Cobleigh?
ScholarIQopenalex
The OpenAlex for Melody Cobleigh is on the source record.
What are the most-cited papers on Melody Cobleigh?
ScholarIQmost cited works
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Kathy D. Miller, Molin Wang, Julie R. Gralow, Maura N. Dickler, Melody Cobleigh, Edith A. Perez, Tamara Shenkier, David Cella, Nancy E. Davidson
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
Marianne J. Brady, David Cella, Fei Mo, Amy E. Bonomi, David S. Tulsky, Stephen Lloyd, Shirley Deasy, Melody Cobleigh, Gail Shiomoto
Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer
Kathy D. Miller, Linnea Chap, Frankie A. Holmes, Melody Cobleigh, P. Kelly Marcom, Louis Fehrenbacher, Maura N. Dickler, Beth Overmoyer, James D. Reimann, Amy P. Sing, Virginia K. Langmuir, Hope S. Rugo
Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100
Bryan P. Schneider, Μolin Wang, Milan Radovich, George W. Sledge, Sunil Badve, Ann D. Thor, David A. Flockhart, Bradley A. Hancock, Nancy E. Davidson, Julie R. Gralow, Maura N. Dickler, Edith A. Perez, Melody Cobleigh, Tamara Shenkier, Susan M. Edgerton, Kathy D. Miller
Evaluation of Clinical Outcomes According to HER2 Detection by Fluorescence In Situ Hybridization in Women with Metastatic Breast Cancer Treated with Trastuzumab
R. Mass, Michael F. Press, Steven M. Anderson, Melody Cobleigh, Charles L. Vogel, Noël Dybdal, Grazyna Leiberman, Dennis J. Slamon